Boehringer Ingelheim Launches External Innovation Hub in China  Boehringer Ingelheim is increasing its efforts to access external innovation in China, recognizing the opportunities offered by the prospering Chinese life science ecosystem, to develop new breakthrough medicines for patients with high unmet medical needsThe External Innovation Hub China formalizes these efforts by co-locating business leaders from Boehringer Ingelheim ’s partnering functions to facilitate access to a range of collaboration opportunities. Academic and biotech institutions will also have access to the Boehringer Ingelheim Venture Fund  The initiative is one element of Boehringer Ingelheim ’s expansion in Asia including recent partnerships in Korea, Singapore and India
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news